BHST
NASD BioHarvest Sciences, Inc.$1.68 ↑ +0.02 (+1.20%) Trading Up from the previous close of $1.66, $0.01 below the day’s high of $1.69
- YTD change
- -67.63%
- vs 20-day SMA
- +8.02%
- vs 200-day SMA
- -52.35%
Price ranges
Price & Performance
-2.79 (-65.07%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 86.9% away from all-time highs of $12.80
- BHST is down 68% since the beginning of the year
- BHST is down 86% over the past 12 months
- BHST is down 10% over the past 1 month
- 1% of all BHST investors are betting against BHST
BHST reads neutral: price sits above one of the two key moving averages, the 12-month move is -87.6%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +12.75%
- vs 8-day SMA
- +13.51%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.
Competitor comparison
| Ticker | Company | Price | Change |
|---|---|---|---|
| TECK.B.CAT | TECK RESOURCES LTD CL B | $92.13 | -1.18% |
| IVN.CAT | IVANHOE MINES LTD COM CL A | $11.16 | -3.88% |
| CGG.CAT | CHINA GOLD INTL RES CORP LTD | $38.29 | -1.74% |
| CS.CAT | CAPSTONE COPPER CORP | $13.58 | -2.44% |
| SSRM.CAT | SSR MINING IN | $47.76 | +2.25% |
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.